NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 3 filers reported holding NEOGENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $137,066 | -22.4% | 11,153 | +1.6% | 0.00% | – |
| Q2 2023 | $176,677 | -54.6% | 10,982 | -74.2% | 0.00% | – |
| Q4 2022 | $389,318 | +85.4% | 42,569 | +78.6% | 0.00% | – |
| Q3 2022 | $210,000 | -53.0% | 23,831 | -32.9% | 0.00% | -100.0% |
| Q1 2022 | $447,000 | -62.8% | 35,506 | +2.1% | 0.00% | 0.0% |
| Q4 2021 | $1,200,000 | +97.0% | 34,762 | +207.9% | 0.00% | 0.0% |
| Q4 2020 | $609,000 | +190.0% | 11,290 | +101.4% | 0.00% | – |
| Q3 2020 | $210,000 | -67.3% | 5,607 | -72.9% | 0.00% | -100.0% |
| Q2 2020 | $642,000 | +121.4% | 20,724 | +108.7% | 0.00% | 0.0% |
| Q4 2019 | $290,000 | +48.7% | 9,931 | -2.4% | 0.00% | – |
| Q3 2019 | $195,000 | – | 10,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
| PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
| Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
| First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
| Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
| Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
| Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
| EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
| Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |